Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB1320 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	II
2	2	119THCONGRESS
3	3	1
4	4	STSESSION S. 1320
5	5	To direct the Secretary of Defense and the Secretary of Veterans Affairs
6	6	to take certain steps regarding research related to menopause,
7	7	perimenopause, or mid-life women’s health, and for other purposes.
8	8	IN THE SENATE OF THE UNITED STATES
9	9	APRIL8, 2025
10	10	Mrs. M
11	11	URRAY(for herself and Ms. ERNST) introduced the following bill; which
12	12	was read twice and referred to the Committee on Veterans’ Affairs
13	13	A BILL
14	14	To direct the Secretary of Defense and the Secretary of
15	15	Veterans Affairs to take certain steps regarding research
16	16	related to menopause, perimenopause, or mid-life wom-
17	17	en’s health, and for other purposes.
18	18	Be it enacted by the Senate and House of Representa-1
19	19	tives of the United States of America in Congress assembled, 2
20	20	SECTION 1. SHORT TITLE. 3
21	21	This Act may be cited as the ‘‘Servicewomen and Vet-4
22	22	erans Menopause Research Act’’. 5
23	23	SEC. 2. DEFINITIONS. 6
24	24	In this Act: 7
25	25	VerDate Sep 11 2014 23:03 Apr 17, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\S1320.IS S1320
26	26	kjohnson on DSK7ZCZBW3PROD with $$_JOB 2
27	27	•S 1320 IS
28	28	(1) COVERED PROVIDER .—The term ‘‘covered 1
29	29	provider’’ means a health care provider employed by 2
30	30	the Department of Defense or the Department of 3
31	31	Veterans Affairs. 4
32	32	(2) M
33	33	ENOPAUSE.—The term ‘‘menopause’’ 5
34	34	means the stage of a woman’s life— 6
35	35	(A) when menstrual periods stop perma-7
36	36	nently and she can no longer get pregnant; and 8
37	37	(B) that is not a disease state, but a nor-9
38	38	mal part of aging for women. 10
39	39	(3) M
40	40	ID-LIFE.—The term ‘‘mid-life’’ means a 11
41	41	life stage that— 12
42	42	(A) coincides with the menopausal transi-13
43	43	tion in women, which may be physical or emo-14
44	44	tional; 15
45	45	(B) encompasses the late reproductive age, 16
46	46	which can begin at approximately 35 years of 17
47	47	age, to the late postmenopausal stages of repro-18
48	48	ductive aging, which can extend to approxi-19
49	49	mately 65 years of age; and 20
50	50	(C) often marks the onset of many chronic 21
51	51	diseases. 22
52	52	(4) P
53	53	ERIMENOPAUSE.—The term 23
54	54	‘‘perimenopause’’ means the time during a woman’s 24
55	55	life when levels of the hormone estrogen fall un-25
56	56	VerDate Sep 11 2014 23:03 Apr 17, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S1320.IS S1320
57	57	kjohnson on DSK7ZCZBW3PROD with $$_JOB 3
58	58	•S 1320 IS
59	59	evenly in a woman’s body and is also called the men-1
60	60	opausal transition. 2
61	61	(5) P
62	62	OSTMENOPAUSAL.—The term ‘‘post-3
63	63	menopausal’’ means the stage of a woman’s life after 4
64	64	a woman has been without a menstrual period for 12 5
65	65	months that lasts for the rest of a woman’s life and 6
66	66	reflects a time when women are at increased risk for 7
67	67	osteoporosis and heart disease. 8
68	68	SEC. 3. EVALUATION OF CERTAIN RESEARCH RELATED TO 9
69	69	MENOPAUSE, PERIMENOPAUSE, OR MID-LIFE 10
70	70	WOMEN’S HEALTH. 11
71	71	(a) I
72	72	NGENERAL.—The Secretary of Defense, in co-12
73	73	ordination with Secretary of Veterans Affairs, shall evalu-13
74	74	ate— 14
75	75	(1) the results of completed research related to 15
76	76	menopause, perimenopause, or mid-life women’s 16
77	77	health among women who are members of the 17
78	78	Armed Forces or veterans; 18
79	79	(2) the status of such research that is ongoing; 19
80	80	(3) any gaps in knowledge and research on— 20
81	81	(A) treatments for menopause-related 21
82	82	symptoms, including hormone and non-hormone 22
83	83	treatments; 23
84	84	(B) the safety and effectiveness of treat-24
85	85	ments for menopause-related symptoms; 25
86	86	VerDate Sep 11 2014 23:03 Apr 17, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\S1320.IS S1320
87	87	kjohnson on DSK7ZCZBW3PROD with $$_JOB 4
88	88	•S 1320 IS
89	89	(C) the relation of service in the Armed 1
90	90	Forces to perimenopause and menopause and 2
91	91	the impact of such service on perimenopause 3
92	92	and menopause; 4
93	93	(D) the effect of combat roles on symp-5
94	94	toms relating to perimenopause and menopause, 6
95	95	including exposure to burn pits, toxic chemicals, 7
96	96	and perfluoroalkyl and polyfluoroalkyl sub-8
97	97	stances (commonly known as ‘‘PFAS’’); and 9
98	98	(E) the impact of perimenopause and 10
99	99	menopause on the mental health of women who 11
100	100	are members of the Armed Forces or veterans; 12
101	101	(4) the availability of and uptake of professional 13
102	102	training resources for covered providers relating to 14
103	103	mid-life women’s health with respect to the care, 15
104	104	treatment, and management of perimenopause and 16
105	105	menopausal symptoms, and related support services; 17
106	106	and 18
107	107	(5) the availability of and uptake of treatments 19
108	108	for women who are members of the Armed Forces 20
109	109	or veterans who are experiencing perimenopause or 21
110	110	menopause. 22
111	111	(b) R
112	112	EPORT; STRATEGICPLAN.—Not later than 180 23
113	113	days after the date of the enactment of this Act, the Sec-24
114	114	VerDate Sep 11 2014 23:03 Apr 17, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\S1320.IS S1320
115	115	kjohnson on DSK7ZCZBW3PROD with $$_JOB 5
116	116	•S 1320 IS
117	117	retary of Defense and the Secretary of Veterans Affairs 1
118	118	shall each submit to Congress a report containing— 2
119	119	(1) the findings of the evaluation conducted 3
120	120	under subsection (a); 4
121	121	(2) recommendations for improving professional 5
122	122	training resources described in subsection (a)(4) for 6
123	123	covered providers; and 7
124	124	(3) a strategic plan that— 8
125	125	(A) resolves the gaps in knowledge and re-9
126	126	search identified in the report; and 10
127	127	(B) identifies topics in need of further re-11
128	128	search relating to potential treatments for 12
129	129	menopause-related symptoms of women who are 13
130	130	members of the Armed Forces or veterans. 14
131	131	(c) N
132	132	ONDUPLICATION AND SUPPLEMENTATION OF 15
133	133	E
134	134	FFORTS.—In carrying out activities under this section, 16
135	135	the Secretary of Defense and the Secretary of Veterans 17
136	136	Affairs shall ensure that such activities minimize duplica-18
137	137	tion and supplement, not supplant, existing information- 19
138	138	sharing efforts of the Department of Health and Human 20
139	139	Services. 21
140	140	VerDate Sep 11 2014 23:03 Apr 17, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\S1320.IS S1320
141	141	kjohnson on DSK7ZCZBW3PROD with $$_JOB 6
142	142	•S 1320 IS
143	143	SEC. 4. SENSE OF CONGRESS ON ADDITIONAL RESEARCH 1
144	144	RELATED TO MENOPAUSE, PERIMENOPAUSE, 2
145	145	OR MID-LIFE WOMEN’S HEALTH. 3
146	146	It is the sense of Congress that the Secretary of De-4
147	147	fense and the Secretary of Veterans Affairs should each 5
148	148	conduct research related to menopause, perimenopause, or 6
149	149	mid-life health regarding women who are members of the 7
150	150	Armed Forces or veterans. 8
151	151	Æ
152	152	VerDate Sep 11 2014 23:03 Apr 17, 2025 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6301 E:\BILLS\S1320.IS S1320
153	153	kjohnson on DSK7ZCZBW3PROD with $$_JOB